Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.
Causeway Therapeutics has raised $10.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.
Causeway Therapeutics's investors include Declan Doogan, Scottish Investment Bank, Mediqventures, Glasgow University Holdings.
Causeway Therapeutics is headquartered in Glasgow, United Kingdom.
Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.
Causeway Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Causeway Therapeutics — Funding & Investors." VCBacked, February 22, 2023, https://www.vcbacked.co/company/causeway-therapeutics. Accessed September 30, 2026.
VCBacked. (2023). Causeway Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/causeway-therapeutics
{{cite web |title=Causeway Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/causeway-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated